Endostatin as a Mediator Between Endothelial Function and Cognitive Performance in Those at Risk for Vascular

Cameron Isaacs-Trepanier1, Mahwesh Saleem2, Nathan Herrmann2,3

  • 1Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.

Insights

Endostatin, an anti-angiogenic marker, mediates the link between endothelial function and cognitive performance in coronary artery disease patients. This finding highlights endostatin

Area of Science:

  • Cardiovascular Research
  • Neuroscience
  • Angiogenesis Research

Background:

  • Coronary artery disease (CAD) patients face higher risks of vascular cognitive impairment.
  • Diminished endothelial function in CAD is linked to poorer cognitive performance.
  • The precise mechanisms connecting endothelial function and cognition in CAD remain unclear, though angiogenesis is a potential mediator.

Purpose of the Study:

  • To investigate whether angiogenesis markers mediate the relationship between endothelial function and cognitive performance in CAD patients.
  • To explore the role of vascular endothelial growth factor (pro-angiogenic) and endostatin (anti-angiogenic) in this association.

Main Methods:

  • Fifty CAD patients underwent assessment of endothelial function via peripheral arterial tonometry.
  • Serum levels of vascular endothelial growth factor and endostatin were quantified.
  • Cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA); mediation analysis with bootstrapping was employed.

Main Results:

  • Endostatin significantly mediated the association between endothelial function and cognitive performance, unlike vascular endothelial growth factor.
  • This mediation effect persisted even when controlling for covariates like education, BMI, and diabetes.
  • The mediation was also significant when using delayed recall scores from the MoCA.

Conclusions:

  • Endostatin plays a mediating role in the relationship between endothelial function and cognitive performance among individuals with coronary artery disease.
  • These findings suggest endostatin as a potential therapeutic target for mitigating cognitive decline in CAD.
Abstract

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
438
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.5K